John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Audit of mortality in type 2 diabetes mellitus

    The British Journal of Diabetes & Vascular Disease Date published:

  • Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us

    American Journal of Hypertension Date published:

  • Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla

    Journal of Comparative Neurology Date published:

  • Challenges for the Prevention of Primary and Secondary Stroke. The importance of lowering blood pressure and total cardiovascular risk

    Blood Pressure Date published:

  • Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus

    Journal of Hypertension, Supplement Date published:

  • A half-century of Australian health and medical research

    Medical Journal of Australia Date published:

  • Prevention of cardiovascular diseases in developing countries

    Journal of Hypertension Date published:

  • Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

    The Lancet Date published:

  • Spinal GABA A receptors do not mediate the sympathetic baroreceptor reflex in the rat

    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Date published:

  • Connecting the dots: ongoing ace inhibition trials and what they can tell us Tuesday, may 16, broadway ballroom north, 5:30 pm to 7:30 pm. ace inhibitors: more than just bp reduction

    American Journal of Hypertension Date published:

  • FIXED VERY-LOW-DOSE COMBINATION PERINDOPRIL 2 mg/INDAPAMIDE 0.625 mg IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION IN VERY ELDERLY PATIENTS (±75 YEARS)

    Journal of Hypertension Date published:

  • ARE VERY ELDERLY HYPERTENSIVE SUBJECTS (≥75 Y) DIFFERENT FROM ELDERLY SUBJECTS (≥65 Y; <75 Y) FOR A FIXED VERY-LOW-DOSE ACE-INHIBITOR/DIURETIC COMBINATION?

    Journal of Hypertension Date published:

  • Blood pressure burden: vascular changes and cerebrovascular complications.

    Journal of Hypertension, Supplement Date published:

  • PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.

    Journal of hypertension. Supplement : official journal of the International Society of Hypertension Date published:

  • Delta pioid receptor immunoreactive boutons appose bulbospinal CI neurons in the rat

    NeuroReport Date published:

  • Global impact of stroke.

    Heart Disease Date published: